OPTHNasdaqPharmaceutical PreparationsFiscal year ends September 30
Optimi Health Corp.
$3.33−0.05 (-1.48%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Optimi Health has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Optimi Health filed with the SEC
Optimi Health to Present at the ThinkEquity Conference
EX-99.1 to Form 6-K
Name and Address of Company
EX-99.1 to Form 6-K
Name and Address of Company
EX-99.1 to Form 6-K
VANCOUVER, British Columbia, August 14, 2026 (GLOBE
EX-99.1 to Form 6-K
This management’s discussion and analysis (“ MD&A ”)
EX-99.1 to Form 6-K
Condensed interim consolidated financial statements
EX-99.2 to Form 6-K
Optimi Health Corp. (Nasdaq: OPTH) reports the open market purchase of 3,800
EX-99.1 to Form 6-K
NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING
EX-99.1 to Form 6-K
EX-99.2 to Form 6-K
EX-99.2 to Form 6-K
EX-99.3 to Form 6-K
EX-99.3 to Form 6-K
This management’s discussion and analysis
EX-99.1 to Form 6-K
Condensed interim consolidated financial statements
EX-99.2 to Form 6-K
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy
EX-99.1 to Form 6-K
Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date
EX-99.1 to Form 6-K